2022
DOI: 10.1111/epi.17157
|View full text |Cite|
|
Sign up to set email alerts
|

Deep brain stimulation targets in epilepsy: Systematic review and meta‐analysis of anterior and centromedian thalamic nuclei and hippocampus

Abstract: Deep brain stimulation (DBS) is a neuromodulatory treatment used in patients with drug-resistant epilepsy (DRE). The primary goal of this systematic review and metaanalysis is to describe recent advancements in the field of DBS for epilepsy, to compare the results of published trials, and to clarify the clinical utility of DBS in DRE. A systematic literature search was performed by two independent authors. Forty-four articles were included in the meta-analysis (23 for anterior thalamic nucleus [ANT], 8 for cen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
67
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(68 citation statements)
references
References 83 publications
1
67
0
Order By: Relevance
“…One direction is based on the deep brain stimulation that aims to verify the functional role of the thalamus during the treatment process. Recent studies have confirmed the satisfactory results of thalamic nucleus deep brain stimulation in drug-resistant generalized epilepsy (Fasano et al, 2021;Vetkas et al, 2022). This approach is effective in clinical practice but is invasive.…”
Section: Introductionmentioning
confidence: 84%
“…One direction is based on the deep brain stimulation that aims to verify the functional role of the thalamus during the treatment process. Recent studies have confirmed the satisfactory results of thalamic nucleus deep brain stimulation in drug-resistant generalized epilepsy (Fasano et al, 2021;Vetkas et al, 2022). This approach is effective in clinical practice but is invasive.…”
Section: Introductionmentioning
confidence: 84%
“…It is well known that there is a close connection between epilepsy and psychiatric comorbidities 1 . According to literature, up to 30% of newly diagnosed people with epilepsy and as much as 50% of people with refractory epilepsy experience psychiatric, psychosocial, or cognitive challenges 2–4 . Refractory epilepsy is a condition that affects all sides of life, and it is associated with increased risk of mortality, morbidities, injuries, and sudden unexpected death in epilepsy (SUDEP), as well as unacceptable side effects of antiepileptic medication.…”
Section: Introductionmentioning
confidence: 99%
“…Refractory epilepsy is a condition that affects all sides of life, and it is associated with increased risk of mortality, morbidities, injuries, and sudden unexpected death in epilepsy (SUDEP), as well as unacceptable side effects of antiepileptic medication. In this context, deep brain stimulation (DBS) has become an important tool shown to be one of the most promising neuromodulatory techniques today 3,4 . The SANTE study, 5 the only double‐blinded randomized study for a long time, showed a sustained effect for 2 years of bilateral stimulation to the ANT, and in the open follow‐up continuation after 5 years a 69% reduction of seizure frequency from baseline 6 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…
To the Editor, We read with great interest the systematic review and meta-analysis by Vetkas et al 1 The authors demonstrated different trends of response with different targets of deep brain stimulation (DBS) among patients with drugresistant epilepsy (DRE). While this study provides important clinical insights about DBS use, we have identified a few concerning biases in the study.The meta-analysis included some studies with a low number of patients, as low as three patients.
…”
mentioning
confidence: 99%